Litcius/Paper detail

Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial

Eliza F. Chakravarty, Tammy O. Utset, Diane L. Kamen, Gabriel Contreras, W. Joseph McCune, Cynthia Aranow, Kenneth Kalunian, Elena Massarotti, Megan E. B. Clowse, Brad H. Rovin, S. Sam Lim, Vikas Majithia, Maria Dall’Era, R. John Looney, Doruk Erkan, Amit Saxena, Nancy J. Olsen, Kichul Ko, Joel M. Guthridge, Ellen Goldmuntz, Jessica Springer, Carla D’Aveta, Lynette Keyes-Elstein, Bill Barry, Ashley Pinckney, James McNamara, Judith A. James

2024The Lancet Rheumatology28 citationsDOIOpen Access PDF

Topics & Concepts

MycophenolateMedicineLupus nephritisMycophenolic acidSystemic lupus erythematosusImmunologyInternal medicineDiseaseTransplantationSystemic Lupus Erythematosus ResearchRenal Transplantation Outcomes and TreatmentsRheumatoid Arthritis Research and Therapies
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial | Litcius